STVN - Stevanato Group S.p.A.
NYSE
->
Healthcare
->
Medical Instruments & Supplies
Piombino Dese,
Italy
Type: Equity
STVN price evolution
STVN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $69.6 | $64.82 | $61.22 | $158.76 |
| Short term investments | $4.38 | $2.4 | $5.14 | $20.06 |
| Net receivables | $345.67 | $268.02 | $276.29 | $273.99 |
| Inventory | $255.32 | $277.15 | $269.26 | $245.45 |
| Total current assets | $861.89 | $788.6 | $769.51 | $831.27 |
| Long term investments | $0.68 | $0.58 | $0.67 | $0.75 |
| Property, plant & equipment | $1046.74 | $984.79 | $878.69 | $756.73 |
| Goodwill & intangible assets | $80.97 | $75.82 | $77.11 | $78.03 |
| Total noncurrent assets | $1209.68 | $1138.35 | $1039.17 | $911.85 |
| Total investments | $5.06 | $2.98 | $5.81 | $20.8 |
| Total assets | $2071.58 | $1926.95 | $1808.69 | $1743.12 |
| Current liabilities | ||||
| Accounts payable | $277.81 | $240.61 | $267.17 | $235.57 |
| Deferred revenue | $22.31 | $9.85 | $11.15 | $10.37 |
| Short long term debt | $143.28 | $100.9 | $68.31 | $84.74 |
| Total current liabilities | $574.39 | $559.95 | $566.05 | $516.03 |
| Long term debt | $255.64 | $196.31 | $120.88 | $143.27 |
| Total noncurrent liabilities | $364.54 | $270.31 | $188.83 | $196.61 |
| Total debt | $398.92 | $297.21 | $189.18 | $228.02 |
| Total liabilities | $938.93 | $830.27 | $754.88 | $712.64 |
| Shareholders' equity | ||||
| Retained earnings | $965.2 | $974.47 | $969.74 | $980.71 |
| Other shareholder equity | $0 | |||
| Total shareholder equity | $1132.53 | $1096.57 | $1053.95 | $1030.67 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $69.6 | $228.74 | $411.04 | $115.6 |
| Short term investments | $4.38 | $33.6 | $27.22 | $41.54 |
| Net receivables | $345.67 | $245.74 | $191.6 | $131.8 |
| Inventory | $255.32 | $213.25 | $148.92 | $139.37 |
| Total current assets | $861.89 | $845.77 | $865.97 | $492.77 |
| Long term investments | $0.68 | $0.78 | $1.08 | $2.77 |
| Property, plant & equipment | $1046.74 | $660.69 | $415.41 | $339.04 |
| Goodwill & intangible assets | $80.97 | $79.4 | $79.17 | $81.14 |
| Total noncurrent assets | $1209.68 | $813.92 | $552.87 | $475.2 |
| Total investments | $5.06 | $34.38 | $28.3 | $44.31 |
| Total assets | $2071.58 | $1659.7 | $1418.84 | $967.98 |
| Current liabilities | ||||
| Accounts payable | $277.81 | $239.18 | $164.79 | $118.74 |
| Deferred revenue | $22.31 | $14.85 | $18.77 | $5.03 |
| Short long term debt | $143.28 | $70.75 | $46.2 | $81.23 |
| Total current liabilities | $574.39 | $462.5 | $338.62 | $316.18 |
| Long term debt | $255.64 | $148.41 | $202.3 | $294.12 |
| Total noncurrent liabilities | $364.54 | $201.29 | $238.56 | $341.66 |
| Total debt | $398.92 | $219.16 | $248.49 | $375.36 |
| Total liabilities | $938.93 | $663.79 | $577.18 | $657.84 |
| Shareholders' equity | ||||
| Retained earnings | $965.2 | $831.58 | $686.05 | $211.98 |
| Other shareholder equity | $0 | |||
| Total shareholder equity | $1132.53 | $996.13 | $842.07 | $310.5 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $320.64 | $271.42 | $255.31 | $237.99 |
| Cost of revenue | $218.8 | $188.52 | $176.4 | $161.73 |
| Gross Profit | $101.83 | $82.89 | $78.9 | $76.26 |
| Operating activities | ||||
| Research & development | $10.07 | $8.69 | $8.36 | $8.55 |
| Selling, general & administrative | $30.71 | $25.24 | $29.7 | $28.27 |
| Total operating expenses | $37.79 | $31.73 | $34.04 | $35.61 |
| Operating income | $64.05 | $51.16 | $44.86 | $40.65 |
| Income from continuing operations | ||||
| EBIT | $68.36 | $55.97 | $51.55 | $45.03 |
| Income tax expense | $13.56 | $12.51 | $10.03 | $7.77 |
| Interest expense | $9.56 | $5.57 | $7.28 | $9 |
| Net income | ||||
| Net income | $45.23 | $37.89 | $34.24 | $28.27 |
| Income (for common shares) | $45.23 | $37.89 | $34.24 | $28.27 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1085.35 | $983.68 | $843.92 | $662.04 |
| Cost of revenue | $745.46 | $663.88 | $578.51 | $467.86 |
| Gross Profit | $339.89 | $319.8 | $265.4 | $194.18 |
| Operating activities | ||||
| Research & development | $35.67 | $34.39 | $29.62 | $17.39 |
| Selling, general & administrative | $113.92 | $111.83 | $82.95 | $78.91 |
| Total operating expenses | $139.17 | $127.37 | $103.18 | $91.07 |
| Operating income | $200.72 | $192.43 | $162.22 | $103.11 |
| Income from continuing operations | ||||
| EBIT | $220.91 | $217.31 | $184.53 | $118.04 |
| Income tax expense | $43.86 | $44.63 | $31.4 | $17.68 |
| Interest expense | $31.42 | $29.84 | $18.81 | $21.85 |
| Net income | ||||
| Net income | $145.63 | $142.85 | $134.32 | $78.51 |
| Income (for common shares) | $145.63 | $142.85 | $134.32 | $78.51 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $45.23 | $37.89 | $34.24 | $28.27 |
| Operating activities | ||||
| Depreciation | $20.06 | $20.54 | $19.51 | $18.37 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $10.19 | $33.51 | $24.37 | $37.13 |
| Investing activities | ||||
| Capital expenditures | -$81.54 | -$131.2 | -$92.19 | -$127.73 |
| Investments | -$2.03 | $0.04 | -$2.17 | -$0.03 |
| Total cash flows from investing | -$64.38 | -$132.16 | -$95.88 | -$128.81 |
| Financing activities | ||||
| Dividends paid | -$10.45 | |||
| Sale and purchase of stock | ||||
| Net borrowings | $98.19 | $105.64 | -$39.31 | $8.05 |
| Total cash flows from financing | $59.83 | $101.55 | -$25.35 | $22 |
| Effect of exchange rate | -$0.86 | $0.7 | -$0.69 | -$0.3 |
| Change in cash and equivalents | $5.64 | $2.9 | -$96.86 | -$69.67 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $145.63 | $142.85 | $134.32 | $78.51 |
| Operating activities | ||||
| Depreciation | $78.48 | $64.82 | $56.38 | $54.1 |
| Business acquisitions & disposals | -$3.59 | $14.81 | ||
| Stock-based compensation | ||||
| Total cash flows from operations | $105.21 | $103.31 | $133.34 | $155.66 |
| Investing activities | ||||
| Capital expenditures | -$432.66 | -$234.88 | -$106.52 | -$89.55 |
| Investments | -$4.19 | $0.03 | $0.77 | -$0.1 |
| Total cash flows from investing | -$421.22 | -$242.95 | -$96.43 | -$96.09 |
| Financing activities | ||||
| Dividends paid | -$14.29 | -$13.5 | -$11.2 | -$8.9 |
| Sale and purchase of stock | $380.09 | |||
| Net borrowings | $172.57 | -$31.04 | -$128.4 | -$17.08 |
| Total cash flows from financing | $158.03 | -$44.54 | $254.85 | -$26.52 |
| Effect of exchange rate | -$1.16 | $1.88 | $3.68 | -$2.84 |
| Change in cash and equivalents | -$157.98 | -$184.17 | $291.76 | $33.05 |
News
Fundamentals
| Market cap | $7.80B |
|---|---|
| Enterprise value | $8.12B |
| Shares outstanding | 264.70M |
| Revenue | $1.09B |
|---|---|
| EBITDA | $299.39M |
| EBIT | $220.91M |
| Net Income | $145.63M |
| Revenue Q/Q | 9.77% |
| Revenue Y/Y | 10.34% |
| P/E ratio | 53.53 |
|---|---|
| EV/Sales | 7.49 |
| EV/EBITDA | 27.14 |
| EV/EBIT | 36.78 |
| P/S ratio | 7.18 |
| P/B ratio | 6.88 |
| Book/Share | 4.28 |
| Cash/Share | 0.26 |
| EPS | $0.55 |
|---|---|
| ROA | 7.72% |
| ROE | 13.50% |
| Debt/Equity | 0.83 |
|---|---|
| Net debt/EBITDA | 2.90 |
| Current ratio | 1.50 |
| Quick ratio | 1.06 |